The FDA on December 21, 2018 approved ULTOMIRIS® for adult patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). ULTOMIRIS® is a product of Alexion Pharmaceuticals, Inc.
Other Pages – Top Ad
Advertisement
Leaving ChemoPrescribe
You are now leaving ChemoPrescribe website.
To return to the website, click on the back arrow on your browser.